secwatch / observer
8-K filed July 27, 2023, 7:59 PM ET ticker STE CIK 0001757898
other confidence high sentiment neutral materiality 0.15

STERIS plc reports results of 2023 Annual General Meeting; all proposals passed

STERIS plc

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

STERIS plc shareholders approved Appointment of Ernst & Young Chartered Accountants as statutory auditor under Irish law at the 2023-07-27 meeting.

Proposal
charter amendment
Outcome
passed
Meeting
2023-07-27
Exact text from the filing
3. The shareholders approved the proposal to appoint Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law to hold office until the conclusion of the Company’s next Annual General Meeting by the following votes: Votes for 83,051,183 Votes against 8,608,501 Abstentions 58,166
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

STERIS plc shareholders approved Election of directors for a one-year term at the 2023-07-27 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-07-27
Exact text from the filing
1. The shareholders elected the nominees named below to the board of directors of the Company (the “Board”), each for a one-year term, and the results of the vote were as follows: Nominee Votes for Votes against Abstentions Broker non-votes Esther M. Alegria 87,930,589 166,648 69,798 3,550,815 Richard C. Breeden 83,412,606 4,674,581 79,848 3,550,815 Daniel A. Carestio 86,828,206 1,301,677 37,152 3,550,815 Cynthia L. Feldmann 78,692,106 5,944,870 3,530,059 3,550,815 Christopher S. Holland 87,150,387 932,962 83,686 3,550,815 Dr. Jacqueline B. Kosecoff 79,498,778 8,597,293 70,964 3,550,815 Paul E. Martin 86,306,636 1,785,736 74,663 3,550,815 Dr. Nirav R. Shah 87,034,737 1,007,908 124,390 3,550,815 Dr. Mohsen M. Sohi 83,787,674 4,300,162 79,199 3,550,815 Dr. Richard M. Steeves 87,059,127 1,031,717 76,191 3,550,815
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

STERIS plc shareholders approved Authorization to determine remuneration of Ernst & Young Chartered Accountants as statutory auditor at the 2023-07-27 meeting.

Proposal
charter amendment
Outcome
passed
Meeting
2023-07-27
Exact text from the filing
4. The shareholders approved the proposal to authorize the Board of the Company or the Audit Committee of the Board to determine the remuneration of Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law by the following votes: Votes for 90,452,843 Votes against 1,215,360 Abstentions 49,647
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

STERIS plc shareholders approved Advisory vote on frequency of say-on-pay votes at the 2023-07-27 meeting.

Proposal
say on pay frequency
Outcome
passed
Meeting
2023-07-27
Exact text from the filing
6. The shareholders approved “one-year” for the proposal to approve, on a non-binding advisory basis whether the non-binding advisory vote on named executive officer compensation should be held every one, two or three years, by the following votes: One Year 87,154,402 Two Years 46,103 Three Years 923,796 Abstentions 42,734 Broker non-votes 3,550,815
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

STERIS plc shareholders approved Advisory vote on compensation of named executive officers at the 2023-07-27 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2023-07-27
Exact text from the filing
5. The shareholders approved the proposal to approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to the disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis and the tabular and narrative disclosure contained in the Company’s proxy statement dated June 7, 2023, by the following votes: Votes for 81,238,272 Votes against 6,841,234 Abstentions 87,529 Broker non-votes 3,550,815
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

STERIS plc shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm for the year ending March 31, 2024 at the 2023-07-27 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-07-27
Exact text from the filing
2. The shareholders approved the proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2024 by the following votes: Votes for 83,026,435 Votes against 8,633,905 Abstentions 57,510
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

STERIS plc shareholders approved Renewal of Board's authority to opt-out of statutory pre-emption rights under Irish law regarding issuance of shares for cash at the 2023-07-27 meeting.

Outcome
passed
Meeting
2023-07-27
Exact text from the filing
8. The shareholders approved the proposal to approve the renewal of the Board’s authority to opt-out of statutory pre-emption rights under Irish law regarding the issuance of shares for cash, by the following votes: Votes for 85,582,812 Votes against 5,955,437 Abstentions 179,601
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

STERIS plc shareholders approved Renewal of Board's authority to issue authorized but unissued shares under Irish law at the 2023-07-27 meeting.

Outcome
passed
Meeting
2023-07-27
Exact text from the filing
7. The shareholders approved the proposal to the renewal of the Board’s authority to issue authorized but unissued shares under Irish law, by the following votes: Votes for 89,904,671 Votes against 1,766,723 Abstentions 46,456
View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

STERIS plc filing history →

Source: SEC EDGAR
accession 0001193125-23-196145
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.